About Matthias Luz
Form D filings for GABA Therapeutics in 2019 list Matthias Luz as director.
Matthias Luz first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Matthias Luz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Matthias Luz works with at each company, as listed on that company's latest Form D.
GABA Therapeutics, Inc. · Form D, Oct 18, 2019
IM
Ian Massey
Executive officer and director
RF
Richard Farrell
Chief Financial Officer and director
FB
Florian Brand
Director
CF
Christian Fibiger
Director
OD
Olivier Dasse
Executive officer
DP
David Putman
Executive officer